Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Qing Wan

Showing results (351-360 of 354) with videos related to

Pageof 36
Sort By:
You have reached the last page of results.This site can display upto 354 results.
Therapeutic Advances in Hematology|January 9, 2025
Prognostic significance of MRD and its correlation with arsenic concentration in pediatric acute promyelocytic leukemia: a retrospective study by SCCLG-APL groupZhong Fan, Liang-Chun Yang, Yi-Qiao Chen, et al.
Cancer|December 17, 2025
Real-world efficacy and adverse events of frontline nilotinib in pediatric chronic myeloid leukemia in chronic phase: A prospective multicenter study from SCCCG[PLUS]-CML 2023Zhong Fan, Qi-Wen Chen, Xiu-Ya Huang, et al.
Pharmacoepidemiology and Drug Safety|June 9, 2026
Early Identification of Differentiation Syndrome During ATRA and Arsenic Therapy in Pediatric NHR-APL: Insights From a 14-Year Multicenter CohortZhong Fan, Liang-Chun Yang, Yi-Qiao Chen, et al.
Frontiers in Oncology|January 6, 2022
Prognostic Value and Outcome for ETV6/RUNX1-Positive Pediatric Acute Lymphoblastic Leukemia: A Report From the South China Children's Leukemia GroupKun-Yin Qiu, Hong-Gui Xu, Xue-Qun Luo, et al.
Pageof 36

Showing results (351-360 of 354) with videos related to

Sort By:
Pageof 36
You have reached the last page of results.This site can display upto 354 results.
Therapeutic Advances in Hematology|January 9, 2025
Prognostic significance of MRD and its correlation with arsenic concentration in pediatric acute promyelocytic leukemia: a retrospective study by SCCLG-APL groupZhong Fan, Liang-Chun Yang, Yi-Qiao Chen, et al.
Cancer|December 17, 2025
Real-world efficacy and adverse events of frontline nilotinib in pediatric chronic myeloid leukemia in chronic phase: A prospective multicenter study from SCCCG[PLUS]-CML 2023Zhong Fan, Qi-Wen Chen, Xiu-Ya Huang, et al.
Pharmacoepidemiology and Drug Safety|June 9, 2026
Early Identification of Differentiation Syndrome During ATRA and Arsenic Therapy in Pediatric NHR-APL: Insights From a 14-Year Multicenter CohortZhong Fan, Liang-Chun Yang, Yi-Qiao Chen, et al.
Frontiers in Oncology|January 6, 2022
Prognostic Value and Outcome for ETV6/RUNX1-Positive Pediatric Acute Lymphoblastic Leukemia: A Report From the South China Children's Leukemia GroupKun-Yin Qiu, Hong-Gui Xu, Xue-Qun Luo, et al.
Pageof 36